register

News & Trends - MedTech & Diagnostics

Sydney cancer centre welcomes new medical technology ahead of grand opening

Health Industry Hub | December 8, 2023 |

MedTech & Diagnostics News: A $52 million integrated cancer treatment facility in Campbelltown, located in south-western Sydney, is swiftly advancing towards its grand opening. The delivery of advanced radiation therapy technology has marked a pivotal juncture in the imminent launch of GenesisCare’s state-of-the-art cancer centre.

Members of the Campbelltown Council, representatives from GenesisCare, consumer advocacy groups, and the construction team, congregated at the site to witness the arrival of the multi-million dollar medical technology equipment. This included the Elekta Versa HD linear accelerator and the Catalyst+ HD surface guidance system from C-RAD, pivotal to facilitating advanced treatments like stereotactic radiosurgery (SRS).

Michael Davis, GenesisCare’s NSW General Manager, emphasised “The arrival of this technology marks a major milestone in the delivery of our new centre. Campbelltown is one of Australia’s fastest growing cities and a key priority for the new Campbelltown centre has been future-proofing services and care to accommodate the growing population not only in Campbelltown but the wider region.”

Recognising the value of firsthand experiences in shaping optimal care, GenesisCare actively engaged with individuals diagnosed with cancer, such as members of its Consumer Representative Panel.

Lee McKerracher, a local resident of Campbelltown and a panel member, expressed her enthusiasm, stating, “I was delighted to hear that a new cancer treatment centre was under construction in Campbelltown to give future patients greater choice close to home. In developing this new centre, I applaud GenesisCare for inviting feedback from people who have previously experienced cancer. It shows vulnerability, but ultimately helps to discover insights that can make such a difference in how a patient interacts with a facility and its team which, in turn, elevates the level of care.”

Set to inaugurate its services in March 2024, the centre aims to provide patients with comprehensive access to advanced integrated cancer treatments, encompassing radiation oncology, medical oncology, immunotherapy, haematology, and allied health care services. Notably, a Wellness Pavilion and access to clinical trials will complement the range of offerings. Additionally, on-site providers will deliver pathology and imaging services under one roof, streamlining the patient experience.

The collaboration between Campbelltown City Council, GenesisCare, construction company Erilyan, and property owner NorthWest Healthcare Properties has yielded this pioneering healthcare precinct, signaling the inaugural phase of a transformative healthcare hub in Campbelltown.

Focusing on environmental sustainability, the precinct aspires to attain a prestigious 6-Star-Green-Star Rating upon completion and evaluation. Embraced by verdant open spaces like Koshigaya Park and strategically positioned in proximity to major transportation routes such as Narellan Road and the M5, the centre promises convenience and accessibility for patients journeying from across the region.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.